Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

Clinical trial NCT00390520 · COMPLETED

Trial details

NCT number: NCT00390520
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-09-01
Primary completion: 2007-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.